Prashant Kumar, Ph.D. received his Ph.D. in molecular biology in 2009 from the Max Planck Institute for Infection Biology in Berlin, Germany. Following this, he undertook postdoctoral training in the laboratory of Prof. Karl Simin at the Department of Cancer Biology at the University of Massachusetts Medical School in Worcester, USA, where he established a novel mouse model of malignant breast cancers. Subsequently, he joined the laboratory of Prof. Jean Paul Thiery, a world renowned authority in the area of epithelial-mesenchymal transition, at the Institute of Molecular and Cell Biology in Singapore. During this period, he was involved in the development of a novel point-of-care diagnostic platform for detection of bladder cancer biomarkers. He is a recipient of prestigious Ramanujan Fellowship awarded by Department of Science and Technology, Government of India (DST) 2015. At IOB, he is focusing on using genomic and proteomic approaches to study cancers. He is also involved in the establishment of a culture method to assess circulating tumor cells (CTCs) harvested from blood samples of patients undergoing neoadjuvant therapy.
E-mail: prashant AT ibioinformatics DOT org